
Overview
Status
Active
Registry date
2003-10-31
Share capital
60,000.00 PLN
Registered address
Kierbedzia 8, 05-850 Ożarów Mazowiecki, Poland
Website
Phone
Electronic delivery address
AE:PL-39589-45987-ACBJF-22
Financials
Revenue history (in k)
Financial insight
- companies.financials.estonianCitCertain
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 6 of 6 financial statements were filed late (the longest delay 382 days for 2021).
- 2025not filed
- 202416/03/2026
- 202331/07/2024
- 202201/08/2023
- 202101/08/2023
- 202023/08/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 4.35mMedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD 738.60kMedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 3.48mMedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 7.05mMedianUSD 883.09kAverageUSD 31.39m
Industry
Offer
- Food supplements
- Probiotics
- Capsules
- Tablets
- Oral drops
- Powder sachets
- Supplement formulations
- Technology services
Certifications: GMP, ISO 22000
Website technology
- Analytics and marketing
- Google Analytics
- Google Tag Manager
Authorized Representatives
Andrzej Jerzy Komar – President
Elżbieta Komar – Zastępca Prezesa
Marta Karaś – Attorney-in-fact (sole)
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Andrzej Jerzy Komarage 68 | 60 | $8,103.73 | 50% |
Elżbieta Komarage 65 | 60 | $8,103.73 | 50% |
Andrzej Jerzy Komar and Elżbieta Komar hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2003-11-14.
18 1020 4476 0000 8902 0314 3401
40 1020 4476 0000 8002 0206 7619
53 1020 4476 0000 8002 0206 7676
Debt
No entries in the National Debtors Register (KRZ).
Public aid
75 public aid cases recorded, with a total value of $393,900.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 7, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | $1,397$1,397 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| Jun 9, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | $1,397$1,397 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| May 5, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | $1,397$1,397 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2017-02-01 | Establishment of a Research and Development Centre for modern forms of dietary supplements and foods for special medical purposes. | $1.2M$1,170,024 | Operational Programme Smart Growth |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| BiotonS.A. | $72,911,351.08 | bioton.com | ||
| Celon PharmaS.A. | $52,550,739.16 | celonpharma.com | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| VipharmS.A. | $30,660,173.61 | vipharm.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com |
Change history
| Date | Event | |
|---|---|---|
| 2016-11-24 | Name change (Chemman → Komarko) | |
| 2016-11-24 | PKD change (Removed: 5 codes; Added: 2 codes) | |
| 2011-05-24 | Switch to PKD 2007 (7 PKD 1997 codes → 13 PKD 2007 codes) | |
| 2003-10-31 | Entered in the register |
FAQ
The main business activity of Komarko focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on October 31, 2003.
The headquarters is located at: Kierbedzia 8, 05-850 Ożarów Mazowiecki.
The share capital of the company is PLN 60,000 (approx. $16,207).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $4,352,872 in 2024, which is a decrease of 23.2% compared to 2023.
Yes, in 2024 the company was profitable, achieving a net profit of $738,595, meaning the company increased its profit by 0.5%.
The largest operating cost category falls under other operating costs. This category amounted to $1,254,738 in 2024, representing 36% of all operating expenses.
Last updated: 2026-04-08